{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:14:56Z","timestamp":1759882496712,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA026946","T32DA007027"],"award-info":[{"award-number":["R01DA026946","T32DA007027"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.drugalcdep.2017.09.020","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T01:02:18Z","timestamp":1507942938000},"page":"85-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Maintenance on naltrexone + amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys"],"prefix":"10.1016","volume":"181","author":[{"given":"Megan J.","family":"Moerke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4949-5246","authenticated-orcid":false,"given":"Matthew L.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kejun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Stevens","family":"Negus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0005","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/0028-3908(87)90256-5","article-title":"Effects of naloxone and diprenorphine on amphetamine-stimulated behavior in guinea pigs and rats","volume":"26","author":"Andrews","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0010","series-title":"Opiate Receptors and Antagonists: From Bench to Clinic","first-page":"371","article-title":"Clinical use of opioid antagonists in the treatment of alcohol dependence","author":"Anton","year":"2009"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0015","first-page":"281768","article-title":"Preclinical determinants of drug choice under concurrent schedules of drug self-administration","volume":"2012","author":"Banks","year":"2012","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tips.2016.11.002","article-title":"Insights from preclinical choice models on treating drug addiction","volume":"38","author":"Banks","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/jpet.110.169276","article-title":"Antinociceptive interactions between Mu-opioid receptor agonists and the serotonin uptake inhibitor clomipramine in rhesus monkeys: role of Mu agonist efficacy","volume":"335","author":"Banks","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0030","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/FBP.0b013e32834d63ac","article-title":"Effects of monoamine releasers with varying selectivity for releasing dopamine\/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys","volume":"22","author":"Banks","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0035","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1038\/npp.2013.180","article-title":"Effects of phendimetrazine treatment on cocaine vs food choice and extended-access cocaine consumption in rhesus monkeys","volume":"38","author":"Banks","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drugalcdep.2013.05.005","article-title":"Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys","volume":"131","author":"Banks","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ijnp\/pyv009","article-title":"Preclinical assessment of lisdexamfetamine as an agonist medication candidate for cocaine addiction: effects in rhesus monkeys trained to discriminate cocaine or to self-administer cocaine in a cocaine versus food choice procedure","volume":"18","author":"Banks","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0050","series-title":"Opiate Receptors and Antagonists: From Bench to Clinic","first-page":"83","article-title":"The chemistry and pharmacology of \u03bc-opioid antagnists","author":"Bidlack","year":"2009"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0055","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/jpet.302.1.264","article-title":"Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys","volume":"302","author":"Bowen","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0060","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0022-3565(25)39577-7","article-title":"Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys","volume":"267","author":"Butelman","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-3565(24)37419-1","article-title":"kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception","volume":"285","author":"Butelman","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-008-1222-8","article-title":"Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats","volume":"200","author":"Chiodo","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0075","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E","article-title":"Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data","volume":"16","author":"Cnaan","year":"1997","journal-title":"Stat. Med."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/jpet.104.073411","article-title":"Assessment of the relative reinforcing strength of cocaine in socially housed monkeys using a choice procedure","volume":"312","author":"Czoty","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0085","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/npp.2010.185","article-title":"Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys","volume":"36","author":"Czoty","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0090","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/pr.115.011668","article-title":"Evaluation of the pipeline for development of medications for cocaine use disorder A review of translational preclinical, human laboratory, and clinical trial research","volume":"68","author":"Czoty","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0095","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0028-3908(78)90031-X","article-title":"Naloxone antagonizes behavioural effects of d-amphetamine in mice and rats","volume":"17","author":"Dettmar","year":"1978","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0100","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0022-3565(25)24051-4","article-title":"Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes","volume":"271","author":"Emmerson","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00427648","article-title":"Effects of d-amphetamine and naloxone on brain stimulation reward","volume":"69","author":"Esposito","year":"1980","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0110","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00428151","article-title":"Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems","volume":"78","author":"Ettenberg","year":"1982","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0022-3565(25)28806-1","article-title":"Nalorphine-induced changes in morphine self-administration in rhesus monkeys","volume":"176","author":"Goldberg","year":"1971","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0120","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","article-title":"Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial","volume":"21","author":"Grabowski","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0125","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2010.175","article-title":"Sustained release d-amphetamine reduces cocaine but not \u2018speedball\u2019-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine\/heroin polydrug abusers","volume":"35","author":"Greenwald","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0130","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0022-3565(25)13070-X","article-title":"The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine\/heroin combinations in rats","volume":"277","author":"Hemby","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"year":"2009","series-title":"Addiction: A Disorder of Choice","author":"Heyman","key":"10.1016\/j.drugalcdep.2017.09.020_bib0135"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0140","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0028-3908(82)90114-9","article-title":"Effects of naloxone on d-amphetamine- and apomorphine-induced behavior","volume":"21","author":"Hitzemann","year":"1982","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3565(25)29807-X","article-title":"Behavioral effects of separate and combined administration of naloxone and d-amphetamine","volume":"189","author":"Holtzman","year":"1974","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00421106","article-title":"Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat","volume":"46","author":"Holtzman","year":"1976","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0155","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/adb.12206","article-title":"Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys","volume":"21","author":"Hutsell","year":"2016","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0160","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1176\/appi.ajp.2008.08020304","article-title":"Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial","volume":"165","author":"Jayaram-Lindstrom","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/FBP.0b013e3283423d55","article-title":"Naltrexone decreases D-amphetamine and ethanol self-administration in rhesus monkeys","volume":"22","author":"Jimenez-Gomez","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0170","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/FBP.0b013e3283641c3d","article-title":"A review of human drug self-administration procedures","volume":"24","author":"Jones","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0376-8716(78)90078-9","article-title":"The effects of naloxone on behavior maintained by cocaine and heroin injections in the rhesus monkey","volume":"3","author":"Killian","year":"1978","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0180","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-3565(24)37416-6","article-title":"Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys","volume":"285","author":"Ko","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1099800404267682","article-title":"A comparison of the general linear mixed model and repeated measures ANOVA using a dataset with multiple missing data points","volume":"6","author":"Krueger","year":"2004","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0190","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.biopsych.2012.05.032","article-title":"Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial","volume":"72","author":"Mariani","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0195","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/JCP.0000000000000488","article-title":"Separate and combined effects of naltrexone and extended-release alprazolam on the reinforcing, subject-rated, and cardiovascular effects of methamphetamine","volume":"36","author":"Marks","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0200","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(25)12759-6","article-title":"Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys","volume":"254","author":"Mello","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0205","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1017\/S1461145714000704","article-title":"Amphetamine induced endogenous opioid release in the human brain detected with [(1)(1)C]carfentanil PET: replication in an independent cohort","volume":"17","author":"Mick","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"year":"2011","series-title":"The National Academies Collection: Reports Funded by National Institutes of Health, Guide for the Care and Use of Laboratory Animals","author":"National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals","key":"10.1016\/j.drugalcdep.2017.09.020_bib0210"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0215","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/npp.2014.322","article-title":"Agonist medications for the treatment of cocaine use disorder","volume":"40","author":"Negus","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0220","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1124\/jpet.300.3.1111","article-title":"Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy","volume":"300","author":"Negus","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(02)00339-3","article-title":"Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys","volume":"70","author":"Negus","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0230","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2004.01.006","article-title":"Effects of chronic methadone treatment on cocaine- and food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys","volume":"74","author":"Negus","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0235","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.npp.1300096","article-title":"Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol","volume":"28","author":"Negus","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0240","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00213-004-1878-7","article-title":"Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys","volume":"176","author":"Negus","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0245","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0140-6736(16)00205-1","article-title":"Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial","volume":"387","author":"Nuijten","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jsat.2010.08.012","article-title":"Efficacy of indirect dopamine agonists for psychostimulant dependence: a systematic review and meta-analysis of randomized controlled trials","volume":"40","author":"Perez-Mana","year":"2011","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0255","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1521-0391.2014.12146.x","article-title":"A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence","volume":"23","author":"Pettinati","year":"2014","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0260","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0265","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3565(24)37557-3","article-title":"Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone","volume":"286","author":"Rowlett","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0270","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/ADM.0000000000000297","article-title":"Extended-release injectable naltrexone (XR-NTX) with intensive psychosocial therapy for amphetamine-dependent persons seeking treatment: a placebo-controlled trial","volume":"11","author":"Runarsdottir","year":"2017","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0275","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/JCP.0b013e3181d21967","article-title":"Cocaine choice in humans during D-amphetamine maintenance","volume":"30","author":"Rush","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0280","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/10550490903077929","article-title":"High-dose naltrexone therapy for cocaine-alcohol dependence","volume":"18","author":"Schmitz","year":"2009","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0285","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0022-3565(24)37462-2","article-title":"Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus","volume":"285","author":"Selley","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0290","series-title":"Opiate Receptors and Antagonists: From Bench to Clinic","first-page":"227","article-title":"Naltrexone for initiation and maintenance of opiate abstinence","author":"Severino","year":"2009"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0295","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-011-2516-9","article-title":"Contribution of both M1 and M4 receptors to muscarinic agonist-mediated attenuation of the cocaine discriminative stimulus in mice","volume":"220","author":"Thomsen","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0300","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0376-8716(00)00166-6","article-title":"The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys","volume":"62","author":"Winger","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.09.020_bib0305","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF02180030","article-title":"Naltrexone blocks amphetamine-induced hyperactivity, but not disruption of social and agonistic behavior in mice and squirrel monkeys","volume":"96","author":"Winslow","year":"1988","journal-title":"Psychopharmacology (Berl.)"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617305033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617305033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:55:05Z","timestamp":1759827305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617305033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":61,"alternative-id":["S0376871617305033"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.09.020","relation":{},"ISSN":["0376-8716"],"issn-type":[{"type":"print","value":"0376-8716"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maintenance on naltrexone+amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}